ABOUT THIS EPISODE
Episode 3 of "The Biotech Pulse" features Geert-Jan Mulder, Managing Partner and one of the founders of Forbion, interviewing Mary Kerr, CEO of NeRRe Therapeutics. They discuss the challenges and opportunities in women's health, particularly in biotech. Mary shares insights into her career journey, emphasizing the need for more focus on women's health, addressing unmet needs in conditions like endometriosis and fibroids. They also touch on the recent success of KaNDy Therapeutics, a non-hormonal treatment for menopausal symptoms, and its acquisition by Bayer. The conversation highlights the evolving landscape and increasing interest in women's health within the biotech and venture capital sectors.
See omnystudio.com/listener for privacy information.
